The state’s Bond Commission, which cancelled several monthly meetings before Election Day, has called a special meeting next week to authorize approximately $267 million in general obligation bond allocations.
Among the agencies set to receive money is Connecticut Innovations, which is in line for $25 million to recapitalize its equity investment programs and another $10 million for regenerative medicine research grants for Yale, UConn and Jackson Labs.
CI was forced to delay its key investment programs in September when its funds ran thin. CI said at the time that it had hoped to get $50 million, but couldn’t because of the cancellations. It hoped to restart programs in early 2015.
“We are pleased to have made the bond commission agenda and look forward to returning to business as usual,” CI Spokeswoman Lauren Carmody said in an email Friday morning. “However, we’d like to wait until those funds are approved before discussing next steps.”
Despite the crunch, CI was still able to award $54,000 in entrepreneur grants last month.
In its investment committee meetings in September and October, CI discussed follow-on investment proposals for a number of companies, including Bioarray Therapeutics in Farmington and CMD Bioscience in New Haven, according to meeting minutes.
Image credit: freedigitalphotos.net
